DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Iodo-Willardiine is an investigational drug.
There have been 11 clinical trials for Iodo-Willardiine. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2014.
The most common disease conditions in clinical trials are Diabetes Mellitus, Neuroblastoma, and Insulin Resistance. The leading clinical trial sponsors are National Cancer Institute (NCI), Institut National de la Santé Et de la Recherche Médicale, France, and University of Texas Southwestern Medical Center.
Recent Clinical Trials for Iodo-Willardiine
|Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]||University of Texas Southwestern Medical Center||N/A|
|Imaging of Advanced Tumours Using I-IAZA||University of Alberta||Phase 1/Phase 2|
|Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases||National Cancer Institute (NCI)||Phase 1|